Feedback
European Shorting
My Portfolios
Browse Gurus
Paul Paul Open to everyone
View Bubble Chart
Export to Microsoft Excel
Embed:
Loading Portfolio...
| id | rsymbol | Symbol | Current Price | Change (%) | Open | High | Low | Volume | Date Added | Cost per share | Quantity | Value | Value Weighting | Gain (%) | Gain ($) | Fair Value ($) | Note | Company | Exchange | Industry | Market Cap ($M) | Sales ($M) | Book Value | Debt to Equity | Yield | Payout | 10-Y Dividend Payout Range | Financial Strength | Profitability | Interest Coverage | 52-W Range | 1-W Change (%) | 4-W Change (%) | 52-W Change (%) | YTD Change (%) | Beta | Short Ratio | P/E | P/S | P/B | 10-Year P/E Range | 10-Year P/S Range | 10-Year P/B Range | PEG | 1-Year Revenue Growth Rate | 5-Year Revenue Growth Rate | 10-Year Revenue Growth Rate | 1-Year EBITDA Growth Rate | 5-Year EBITDA Growth Rate | 10-Year EBITDA Growth Rate | NCAV | Median PS Value | Graham Number | Peter Lynch Fair Value | Earnings Yield | Forward Rate of Return | Shiller P/E | EV/EBIT | EV/EBITDA | Predictability Rank | Operating Margin | Net Margin | Cash per Share | ROE | ROA | Altman Z Score | Piotroski F Score | Beneish M Score | EV/Sales |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 432308 | THOR | THOR | 31.34 | -0.15 (-0.48%) | 31.47 | 31.79 | 31.34 | 311K | 11/21/2012 | 37.52 | 0 | 0.00 | 0% | -16.47% | 0.00 | Add | Thoratec Corporation | NAS(USA) | Medical Devices | 1831.5 | 482.61 | 10.36 | 0 | 0.00 | 0 | 88.5 | 70.2 | 10000 | 29.39 39.86 |
-6.67 | -12.38 | 1.58 | -16.07 | 0.86 | 626 | 38.20 | 3.90 | 3.00 | 22.61 50 |
2.61 10 |
0.86 10 |
1.7 | 9.9 | 11.2 | 12.4 | -41.3 | 22.2 | 24.6 | 1.52 | 37.76 | 11.46 | 20.58 | 3.80 | 31.55 | 42 | 26.3 | 20.38 |
Back Testing Results: Average gain of all 3-Star stocks: 8.2% per year. % of Stocks that are in still loss if held for 10yrs: 11%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
15.40 | 11.4 | 2.58 | 9.4 | 8 | 14.21 | 5 | -2.86 | 0.38 | ||
| 432306 | AGN | AGN | 98.00 | -0.45 (-0.46%) | 98.83 | 99.65 | 97.86 | 2.1M | 11/21/2012 | 90.90 | 0 | 0.00 | 0% | 7.81% | 0.00 | Add | Allergan, Inc. | NYSE(USA) | Drug Manufacturers - Specialty & Generic | 28763.6 | 5917.8 | 19.59 | 0.28 | 0.20 | 0.0693 | 0.056 102.667 |
76.9 | 83.5 | 28.4 | 81.28 116.45 |
-5.16 | -13.4 | 11.17 | 7.43 | 0.8 | 428 | 33.80 | 5.10 | 5.20 | 16.53 50 |
2.19 7.53 |
2.42 10 |
2.3 | 7.5 | 7.5 | 12.2 | 11.3 | 15.3 | 28.5 | 2.39 | 97.25 | 24.96 | 35.74 | 5.50 | 14.29 | 46.5 | 18.2 | 15.65 |
Back Testing Results: Average gain of all 3-Star stocks: 8.2% per year. % of Stocks that are in still loss if held for 10yrs: 11%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies |
27.80 | 18.9 | -1.28 | 18.8 | 12 | 6.69 | 6 | -2.82 | -0.13 | |
| Summary | -0.30 (-0.47%) | 0.00 | -4.33% | 0.00 | 36 | 4.5 | 4.1 | 36 | 4.5 | 4.1 |
RSS